News | Radiation Oncology | May 23, 2023

Centre de Cancérologie de la Porte de Saint-Cloud in Boulogne unveils the latest advance in completely non-invasive brain tumor therapy

Centre de Cancérologie de la Porte de Saint-Cloud in Boulogne unveils the latest advance in completely non-invasive brain tumor therapy

May 23, 2023 — ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) in Boulogne, France, has initiated patient treatments with the ground-breaking ZAP-X Gyroscopic Radiosurgery platform. CCPSC is the first in France to offer ZAP-X and is part of the renowned American Hospital of Paris, known for offering the most innovative technologies and most advanced treatment methods. CCPSC treated three patients on their first day, each with a single brain metastasis.

As a non-invasive and painless treatment for select primary and metastatic brain tumors, stereotactic radiosurgery (SRS) has proven to provide equivalent to superior outcomes compared to costly and potentially debilitating surgeries. SRS is typically delivered in one to five brief outpatient visits and patients often return to normal activity the same day as the procedure.

“Because of the significant percentage of cancer patients who develop brain metastases, it was imperative we support our radiation oncology program with a dedicated SRS solution such as ZAP-X,” said Dr. Bacem Belghith, radiation oncologist at the CCPSC.

“As ZAP-X is designed specifically for cranial radiosurgery it allows us to treat the most challenging cases with confidence,” added Dr. Alain Allaw, radiation oncologist at the CCPSC. “And unlike multi-purpose radiotherapy devices, ZAP-X provides patients with potentially lower healthy brain exposure to radiation, and thus enables greater flexibility for our clinical team to treat recurring brain metastases patients.”

The ZAP-X system uses unique gyroscopic mobility to direct radiosurgical beams from hundreds of angles to precisely concentrate radiation on the tumor target. This pioneering approach supports the clinical objective of protecting healthy brain tissue and patient cognitive function.

As the first and only vault-free and cobalt-free dedicated SRS delivery system, ZAP-X also eliminates the expense of building costly shielded radiation treatment rooms, and removes the need to maintain, secure and regularly replace live radioactive isotopes.

“As the first center to retrofit an existing shielded radiotherapy suite, ZAP-X has seamlessly integrated into CCPSC’s busy radiation oncology department, and now serves as the centerpiece of an elite SRS program,” said Hakan Baraner, ZAP Surgical’s Senior Vice President for Europe, India, Middle East, and Africa (EIMEA). “ZAP is incredibly honored to support CCPSC in bringing world-class care to their patients.”

To view video footage of CCPSC’s ZAP-X treatment suite please visit:

For more information:

Related Brain Metastases Content: 

Novel Radiomic Model Helps Predict the Treatment Response of Radiotherapy in Patients with Brain Metastases

PET Imaging Adds Valuable Information to Brain Metastasis Monitoring 

Blue Earth Diagnostics Announces Dosing of Initial Patient in Phase 3 REVELATE Clinical Trial of 18F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases 

Radiosurgery Reduces Cognitive Decline Without Compromising Survival for Patients with 4+ Brain Metastases 

ASTRO Issues Clinical Guideline on Radiation Therapy for Brain Metastases 

Related Content

News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
News | Information Technology

June 4, 2024 — International medical imaging IT and cybersecurity company Sectra has launched a new diagnostic IT module ...

Time June 04, 2024
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
Subscribe Now